Mr. Peter Cicala is the Chief Patent Counsel and Vice President of Intellectual Property at Celgene Corporation. His legal practice focuses on all aspects of pharmaceutical and biotechnology intellectual property law. He has extensive experience in patent litigation, prosecution, product lifecycle management, R&D collaborations and joint ventures in the pharma/biotech industry. Mr. Cicala has particular expertise with Hatch-Waxman Paragraph IV litigation as well as substantial experience with patent and regulatory litigation in Europe. Mr. Cicala has regularly participated in due diligence investigations, patent, trademark and copyright licensing, as well as M&A transactions and patent litigation settlements. Additionally, Mr. Cicala has over 10 years of experience as a medicinal chemist and has worked in drug development programs for several major pharmaceutical companies and universities.
The Federalist Society takes no position on particular legal or public policy issues. The people listed as Experts have spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. All expressions of opinion by an expert are those of the expert.
Intellectual Property Practice Group Podcast
June 17, 2015